250mg Gefitinib Tablets IP

250mg Gefitinib Tablets IP Specification

Brand Name
Gefitinib Tablets IP

Origin of Medicine
India

Indication
Treatment of locally advanced or metastatic non-small cell lung cancer with EGFR mutations

Salt Composition
Gefitinib 250mg

Packaging Type
Blister Pack

Life Span
24 months

Dosage Form
Oral tablets

Pacakaging (Quantity Per Box)
30 tablets per box

Drug Type
Allopathic

Ingredients
Gefitinib

Physical Form
Tablets

Function
Anticancer (Epidermal Growth Factor Receptor Inhibitor)

Recommended For
Non-Small Cell Lung Cancer (NSCLC)

Dosage
250mg once daily or as prescribed by a physician

Dosage Guidelines
Take with or without food. Follow the physicians instructions strictly.

Suitable For
Adults

Quantity
30 Tablets per box

Storage Instructions
Store in a cool, dry place below 30C. Protect from light and moisture.

Marketed By
As per packaging

Prescription Required
Yes

Shape
Film-coated round tablet

Side Effects
Common: diarrhea, rash, acne, nausea, dry skin

Regulatory Status
IP (Indian Pharmacopoeia) Standard

Contraindications
Hypersensitivity to Gefitinib

Warning
To be used under medical supervision only

Administration Route
Oral

Color
White or off-white

Therapeutic Class
Antineoplastic Agents

Strength
250mg per tablet

250mg Gefitinib Tablets IP Trade Information

Minimum Order Quantity
10 Boxes

Payment Terms
Cash Against Delivery (CAD), Cash on Delivery (COD), Cash in Advance (CID)

Supply Ability
100 Boxes Per Month

Delivery Time
5-7 Days

Main Domestic Market
All India

About 250mg Gefitinib Tablets IP

Get your hands on the rare 250mg Gefitinib Tablets IP, a top-drawer anticancer therapy, now available in limited supply and ending soon. Developed to IP standards and decorated with unmatchable clinical efficacy, each film-coated, round, white or off-white tablet delivers precise dosage for adults battling non-small cell lung cancer (NSCLC) with EGFR mutations. This high-strength, prescription-only solution is supplied in a 30-tablet blister pack, ensuring top-tier storage and protection. Store properly and use strictly under medical supervision for optimal therapeutic results.

Commercial Applications and Usage Details

Gefitinib 250mg Tablets IP is utilized primarily in the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) in adults with EGFR mutations. This oral, prescription-only medicine is recommended for professional medical use, strictly following a physician's guidance. With a regimen of 250mg once daily, the site of application is systemic, absorbed through the gastrointestinal tract. The tablets deliver reliable, easy-to-administer cancer therapy, making them indispensable in oncology centers and hospital settings.

Supply Ability, Payment, and Market Information

Gefitinib 250mg Tablets IP offers substantial market value and is recognized for its stable list price within the competitive oncology segment. Suppliers in India maintain robust supply ability to meet urgent hospital and pharmacy proposals. Payment terms are typically flexible, with options tailored to the proposal amount and institutional requirements. This top-drawer medication is widely distributed across the main domestic market, ensuring timely access for health care providers and patients nationwide.

FAQ's of 250mg Gefitinib Tablets IP:

Q: How should Gefitinib 250mg Tablets IP be taken for optimal results?

A: Gefitinib 250mg Tablets IP should be taken orally, once daily, with or without food. Always follow your physician's specific instructions regarding dosing and duration.

Q: What are the primary commercial uses of these tablets?

A: These tablets are mainly used in the treatment of adults with locally advanced or metastatic non-small cell lung cancer that has EGFR mutations. They are prescribed as part of specialized cancer therapy.

Q: When is Gefitinib contraindicated for patients?

A: Gefitinib Tablets IP should not be used by individuals with known hypersensitivity to Gefitinib or any of its ingredients. Always consult with your physician before starting therapy.

Q: Where should these tablets be stored to ensure safety and efficacy?

A: Store Gefitinib Tablets IP in a cool, dry place below 30C, and protect them from light and moisture. Keep them out of reach of children.

Q: What is the process for obtaining Gefitinib Tablets IP?

A: As these are prescription-only medicines, you will need to obtain a valid medical prescription from your physician. Purchase from approved suppliers or pharmacies as per packaging guidelines.